Skip to content

13F-HR filed by ROYCE & ASSOCIATES LP

ROYCE & ASSOCIATES LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-10, with 1,012 holding rows worth $14,875,553,000.

Accession
0000906304-21-000097
Filed
2021-05-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A combination report, 1,012 entries on the cover page, a total value of $14,875,553,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $14,875,553,000 with VALUE read as thousands by filing date, 13F file number 028-03780. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerFranklin Resources, Inc. 028-00734

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SUPERIOR INDS INTL INC868168105COM30,572$174,000thousands by filing date
TALOS ENERGY INC87484T108COM13,626$164,000thousands by filing date
BENEFITFOCUS INC08180D106COM10,600$146,000thousands by filing date
ANTERO RESOURCES CORP COM03674X106Stock13,390$137,000thousands by filing date
OIL STS INTL INC678026105COM18,753$113,000thousands by filing date
SIRIUSPOINT LTDG8192H106COM10,476$107,000thousands by filing date
DAKTRONICS INC234264109COM16,823$105,000thousands by filing date
PEABODY ENGR CORP704551100COM32,199$99,000thousands by filing date
PORTMAN RIDGE FIN CORP73688F102COM32,829$71,000thousands by filing date
Berry Corp08579X101Common Stock12,538$69,000thousands by filing date
RVL PHARMACEUTICALS PLCG6S41R101COM12,115$39,000thousands by filing date
Indivior Pharmaceuticals Inc04546C106COMMON STOCK27,224$19,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000906304-21-000097this filing2021-05-10acceptance time not in the bulk data set